Caelus Health is developing a new class of Microbiome Therapeutics for the reduction of insulin resistance and prevention of Type 2 Diabetes (T2DM) in people with metabolic syndrome.
“NIZO’s expertise in the production of strict anaerobes, and their in-house, food grade facilities, have been critical in ensuring adequate volumes of viable bacteria for our Phase I and Phase II clinical trials. Furthermore, they consistently provided us with science-based process improvements for optimising the production of our next-generation probiotic, both upstream and downstream. NIZO is a knowledgeable and supportive partner for any early-stage project.” – Luc Sterkman, CEO Cealus Health
Based in Ede, the Netherlands, NIZO is a globally leading, private, and independent contract research organization specializing in food and health innovation for over 75 years. Operating the largest open access food-grade pilot plant in Europe, we leverage the integrated power of science and technology to help our customers in transforming food and nutrition more successfully, sustainably and efficiently; ultimately leading to better food and health.
As a NIZO customer, you will benefit from exclusive access to the NIZO Pilot Plant – the largest open-access, food-grade pilot plant in Europe – equipped with €5 million in recent state-of-the-art upgrades.
